The aim of the study was to compare 5 methods of delivering a weight loss lifestyle modification program to obese patients on a background of sibutramine. The methods differed in the type and frequency of counseling utilized to deliver dietary, physical activity and behavioral recommendations for weight loss.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Enrollment
350
Pfizer Investigational Site
Los Angeles, California, United States
Pfizer Investigational Site
Clearwater, Florida, United States
Pfizer Investigational Site
Kissimmee, Florida, United States
Percentage change in body weight at 6 months.
Changes in waist circumference, lipids, glucose, insulin, blood pressure, quality of life and weight-related symptoms at 6 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Pfizer Investigational Site
Pembroke Pines, Florida, United States
Pfizer Investigational Site
Lexington, Kentucky, United States
Pfizer Investigational Site
Louisville, Kentucky, United States
Pfizer Investigational Site
Milford, Massachusetts, United States
Pfizer Investigational Site
Charlotte, North Carolina, United States
Pfizer Investigational Site
Harleysville, Pennsylvania, United States
Pfizer Investigational Site
Warwick, Rhode Island, United States
...and 2 more locations